Scinai Immunotherapeutics Ltd.
SCNI- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001611747
No open-market purchases or sales by Scinai Immunotherapeutics Ltd. insiders were filed in the last 90 days; 11 institutions reported holding it in 13F filings for Q2 2026, worth $49.1K in total; no superinvestor holds it.
Holders of 5% or more of SCNI
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Scinai Immunotherapeutics Ltd., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Stone Daniel E. | 13G/A | 9.90%346.7K shares | 0.00 ppfrom 9.90% | Jan 24, 20253 filings | Feb 17, 2026 | SEC |
| YA II PN, Ltd. | 13G | 9.90%93.3K shares | New | Mar 26, 20251 filing | Mar 26, 2025 | SEC |
| LCK JNK 1 LLC | 13G/A | 9.50%80.8K shares | 0.00 ppfrom 9.50% | Feb 24, 20252 filings | Mar 4, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
7 Schedule 13D and 13G filings on Scinai Immunotherapeutics Ltd., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 17, 20261:14 PM ET | Stone Daniel E.and 1 other | 13G/A | 9.90%346.7K shares | 0.00 ppfrom 9.90% | Dec 31, 2025 | SEC |
| Oct 1, 20255:32 PM ET | Stone Daniel E.and 1 other | 13G/A | 9.90%346.7K shares | −0.09 ppfrom 9.99% | Sep 29, 2025 | SEC |
| Mar 26, 20256:22 PM ET | YA II PN, Ltd.and 7 others | 13G | 9.90%93.3K shares | New | Mar 24, 2025 | SEC |
| Mar 4, 20259:58 PM ET | LCK JNK 1 LLC | 13G/A | 9.50%80.8K shares | 0.00 ppfrom 9.50% | Feb 9, 2025 | SEC |
| Feb 24, 20256:04 AM ET | LCK JNK 1 LLC | 13G | 9.50%80.8K shares | New | Feb 9, 2025 | SEC |
| Jan 24, 20259:21 PM ET | Stone Daniel E. | 13G/A | 9.99%87.7K shares | – | Dec 31, 2024 | SEC |
| Jan 3, 20256:16 PM ET | Sabby Management, LLCand 2 others | 13G | 4.90%29.1K shares | NewBelow 5% | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Scinai Immunotherapeutics Ltd. shares.
No Form 144 notices for Scinai Immunotherapeutics Ltd. are on file.